Sonde Market Data / UK sub-£50m private market

£2.19bn across 2,834 companies.

The early read, 20 days after quarter-end. Like for like, capital is level with a year ago and more companies are raising, but almost all of the extra ones raised under £100k. At the top, twelve companies raised £50m or more, the most in any third quarter since 2021, and eight of them in announced venture rounds.

Published 20 October 2026 Built from every SH01 filed with Companies House Methodology ↓
Capital raised
£2,194m
Q3 2025 · £2,527m · £2,165m at day 20
level, like for like
Companies raising
2,834
Q3 2025 · 2,907 · 2,301 at day 20
ahead, mostly small
Average raise
£0.77m
Q3 2025 · £0.94m at day 20
more small raises
Mega-deals · £50m+
12 / £1.96bn
Q3 2025 · 10 / £1.13bn
eight are real rounds
Year to date
£7.47bn
9M 2025 · £7.24bn
ahead already

Published 20 days after quarter-end, when a quarter typically has about four-fifths of its capital on file. "At day 20" is the same quarter a year earlier as it stood 20 days after it ended, so the comparison is like for like. The whole series is revised since the Q2 edition. See methodology.

Headline / 01 Capital is level with a year ago Twenty days after quarter-end, Q3 2026 has £2.19bn on file. Q3 2025 had £2.16bn at the same point and finished at £2.53bn.
Headline / 02 The extra companies are small Like for like, 1,721 companies raised under £100k, a third more than a year ago. Rounds of £1m to £10m are level: 274 against 274.
Headline / 03 2026 is tracking above a three-year plateau 2023, 2024 and 2025 each raised £10.1–10.5bn. H1 2026 is 12% ahead of H1 2025, which puts the full year at £10.7–11.8bn: above the plateau, below the 2022 peak of £12.5bn.

The quarter / 01

Twenty days in, Q3 is
tracking level with last year.

Sub-£50m capital raised per quarter £m · Q1 2019 – Q3 2026
Quarter Third quarters Q2 2026 Q3 2026

The last bar is still filing. Twenty days after they ended, the ten quarters before it had between 76.4% and 92.1% of their capital on file; on that range Q3 2026 finishes between £2.4bn and £2.9bn, around Q3 2025's £2.53bn, and a little higher once the filings we are still reading are counted.

The year / 02

Three years level at £10.1–10.5bn.
2026 is tracking above them.

Annual sub-£50m capital £bn · 2026 = forecast range
2026 forecast
£10.7–11.8bn
£9.5bn 2025 · £10.5bn £12.5bn

The forecast rests on the first half, because Q3 is still filing. H1's share of the year has moved between 52.0% (2022) and 44.9% (2025): the four-year average lands 2026 near £10.7bn, last year's H2-heavy pattern near £11.8bn. Both ends sit above 2025's £10.5bn and below 2022's £12.5bn.

Funding events
12,3212024 · the peak
12,0182025 · level
9,3042026 · to date, Q3 still filing

2026 has already passed the 8,978 events of the first nine months of 2025. Rounds of £100k and up are level with a year ago; the extra events are almost all smaller, which is why the average raise has slipped.

Stages / 03

Where in the stack
the money went.

Seed9.0% of capital
£198m
855 companies
Series A22.1% of capital
£486m
467 companies
Series B & later67.2% of capital
£1.47bn
387 companies
67% → <14%
67% of the capital went to under 14% of the companies.

The money stays at the top while the count grows at the bottom: the quarter added companies almost entirely below £100k. A further £37m went to 1,125 pre-seed and bootstrapped companies.

Sectors / 04

Software cools. AI and deep tech
take more of the capital.

SectorCapital · Q3 vs Q2 Q3 2026vs Q2
Life sciences260 companies · Q2: 267
£253m
Q2 · £378m
▼ capital −33%
Fintech159 companies · Q2: 191
£202m
Q2 · £358m
▼ capital −44%
AI · pure-play67 companies · Q2: 78
£180m
Q2 · £120m
▲ capital +50%
Deeptech52 companies · Q2: 55
£167m
Q2 · £111m
▲ capital +50%
SaaS188 companies · Q2: 237
£140m
Q2 · £229m
▼ capital −39%
Q2 figures are as filed 20 days after Q2 ended, the same point in the filing cycle as this quarter, so each move measures the market rather than the filing lag. Life sciences = biotech (£166m) + healthtech (£49m) + medtech (£38m). Every company sits in one sector only, the one that best describes what it does, so no round is counted twice.
2.4×AI theme vs label

Companies applying AI raised 2.4 times what pure-play AI raised, across four times the companies.

Applying AI: inside fintech, SaaS, drug discovery, deeptech and beyond£425m · 267 cos
Pure-play AI: AI as the headline identity£180m · 67 cos

Like for like the AI theme is up 28% on a year ago, from £331m at the same point in Q3 2025, and at £425m it is larger than any named sector. Pure-play AI is up 60% on the same point last year, from £113m.

The top end / 05

Twelve mega-deals.
Eight real rounds.

£1.71bn genuine UK venture £256m not venture, of £1.96bn total
£638m
Fluidstack$830m Series A · $7.5bn valuation
AI Genuine VC
£259m
Oxford Quantum Circuits£260m Series C, the British Business Bank anchoring £100m
Genuine VC
£239m
Olix Computing$312m Series B · $3.3bn valuation
AI Genuine VC
£202m
Cambridge Aerospace$300m Series C · $3.4bn valuation
Genuine VC
£147m
Kraken Technology Group$175m Series B for maritime defence drones · $1bn valuation
Genuine VC
£85m
Humanoid (SKL Robotics)First tranche of a $152m Series A · $1.35bn valuation
Genuine VC
£82m
Basecamp ResearchPart of a $140m Series C
Genuine VC
£57m
Callosum TechnologiesFirst close of a $100m seed round
Genuine VC
+4
The rest of the mega layerAn acquisition completing, an owner funding a football club, an owner capitalising a London hotel and a newly listed US parent funding its UK arm
Not venture

Twelve companies raised £50m or more in Q3, totalling £1.96bn, and £1.71bn of it is confirmed UK venture capital in eight announced rounds: AI compute, quantum computing, defence and drones, robotics and AI-led biology.

Two more filings that read as £50m+ rounds are not in these figures. We read both forms: one put the allotment's total nominal value in the per-share price box, the other priced a dollar round in a sterling share class. This is why the headline series is sub-£50m: the top end moves on a handful of filings, and it is the segment below it that UK angels, EIS and SEIS funds actually deploy into.

Announced / 06

Thirteen announced raises.
Eight are still filing.

$450m
CuspAISeries B · Kleiner Perkins and NEA · announced 20 July · £123m filed so far
Part filed
€300m
Open CosmosSeries C, part venture debt · Lightrock and ETF Partners · announced 14 September · £42m filed so far
Part filed
$312m
Olix ComputingSeries B · announced 3 August
Filed
$300m
Cambridge AerospaceSeries C · DFJ Growth · announced 10 August
Filed
$175m
Kraken Technology GroupSeries B for maritime drones · DTCP · announced 9 July
Filed
$152m
Humanoid (SKL Robotics)Series A · Prime Movers Lab · announced 21 July · £85m filed so far
Part filed
$140m
Basecamp ResearchSeries C · S32 · announced 23 September · £82m filed so far
Part filed
£100m
NexeonBacked by the National Wealth Fund · announced 31 August · £49m filed so far
Part filed
$100m
Callosum TechnologiesSeed · Atomico · announced 20 August · £57m filed so far
Part filed
$95m
DwellySeries B equity, beside $75m of debt · EQT Growth · announced 28 July · £48m filed so far
Part filed
$90m
Scan.comSeries C equity, beside $130m of debt · Noteus Partners · announced 31 August · £18m filed so far
Part filed
$65m
Draig TherapeuticsSeries B · Deep Track Capital · announced 14 July · filed in dollars, so outside the sterling series
Filed
$60m
MetaviewSeries C · Insight Partners · announced 30 September · raised through a parent company outside the UK
Raised abroad

What announcements catch. They come first, and they see past the border. Eight of these rounds are only partly on file so far, Open Cosmos's and Scan.com's furthest behind, and Metaview's $60m was raised through a parent company outside the UK, so no UK filing will ever show it.

What filings add. Every allotment of every size, announced or not, with the exact amount and the price per share, and a round arriving tranche by tranche: the gap between announced and filed above is the part still to come.

UK equity rounds first announced between 1 July and 30 September 2026, found by our news reader and checked against each company's own announcement. Amounts as announced; where a round mixed equity and debt, the equity part. Rounds announced earlier but allotted in Q3, such as Oxford Quantum Circuits' June Series C, appear in the filings instead.

Regions / 07

Where the capital lands.

53%
of Q3 sub-£50m capital went to companies registered in London

Outside London and the South East, the North West led the quarter with £212m across 200 companies.

RegionCapital£mCos
London 1,156 1,324
South East 258 381
North West 212 200
East of England 204 226
North East 83 46
Yorkshire & the Humber 68 88
Scotland 67 116
South West 53 162
East Midlands 48 76
West Midlands 26 136
Wales 12 48
Northern Ireland 7 31
By registered office, mapped from postcode area to region, because the Companies House region field is populated for only about a quarter of these companies. Every company in the quarter mapped to a region. A registered office is not always where a company operates; it is frequently an adviser's address, which biases the split toward city centres and toward London in particular.

Quarterly briefing

Get Q4 before it publishes.

We publish roughly three weeks after quarter-end, ahead of most coverage. Wealth managers, IFAs and institutional allocators can get the data briefing first.

One email per quarter. No spam, unsubscribe any time.

Methodology / 08

How we count.

10.6M
SH01 & CS01 filings parsed, back to 2016
34k
UK companies with a priced round in this series
31
quarters in the series behind this page
88k
company-quarter funding events, each traceable to filings

The dataset

Sonde parses every SH01, the statutory return of allotment of shares, lodged with Companies House by UK private companies. Each filing is the legal record of new shares issued. We structure the filings, strip out those that are not genuine private fundraising, and aggregate by company within each calendar quarter, so a company filing multiple SH01s in a quarter counts once.

Where a filing has been formally corrected via a later RP04, we use the corrected values and exclude the superseded original.

Definitions

Mega-deals are companies raising £50m or more within a quarter, reported separately because a handful of outsized entries would otherwise swing the totals. Sectors are assigned by our classification of each company's activity; early-stage companies without a confident classification are reported as unclassified rather than guessed. Regions follow the company's registered office.

The headline series is sub-£50m: the segment UK angels, EIS and SEIS funds deploy into.

What we exclude

✕PLCs: public-market placings, not private rounds; judged on the date of the allotment
✕Par or nominal-price allotments: these signal intra-group capitalisations
✕Obvious filer errors: per-share price above £10,000 or totals above £500m, corrected or excluded
✕Shares paid in kind: issued for a business, other shares or services, not for cash
✕Non-GBP allotments: the series is a sterling one
✕Majority-owned subsidiaries: a single corporate shareholder above 50% when the shares were issued indicates intra-group movement
✕Holding vehicles: TOPCO / MIDCO / BIDCO / HOLDCO entities are financing-structure layers, not operating companies, except a venture business that has moved under a new parent
Revisions

Early, and occasionally revised

We publish three weeks after quarter-end, ahead of most coverage. The price of being early is revision: an SH01 is due a month after the allotment, so this quarter is still filing and will rise, and we are still reading some of the filings already in. Every comparison with an earlier quarter on this page is like for like, that quarter as it stood the same number of days after it ended.

This edition revises the whole series up. Since the Q2 edition we have read about 39,000 filings from companies in sectors our pipeline used to skip (property, construction, hospitality, retail, health and education among them), recovered filings that had failed to download, and corrected cap-table readings that had wrongly marked independent companies as subsidiaries. Q2 2026 now reads £3.02bn across 3,268 companies, against £2.51bn and 2,421 when we published it, and Q2 2025 moves from £2.15bn to £2.60bn.

The method now judges every company as it stood when it issued the shares. Public or private is read from the date of the allotment, and so is whether a company was a subsidiary: earlier editions read that from the latest confirmation statement, so a startup bought by a corporate after it raised lost all its earlier rounds. Shares paid for in kind no longer count, and a venture business that moves under a new parent is followed there. Recent quarters barely move; older years rise, 2019 from £5.5bn to £7.1bn, so growth since 2019 is about half what the old method showed, in line with other market data.

This page was first published on 20 October with the subsidiary test read from the latest confirmation statement, and revised the same day. Q3 2026 moved from £2.18bn to £2.19bn; the history before 2024 moved most.

Every figure on this page comes from a single pull dated 20 October 2026. We flag revisions when they happen, and we do not mix pulls.

Every number on this page
traces back to a filing.